Merit Medical Systems | MMSI - Cost Of Sales


Merit Medical Systems reported $198.58M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
3M USD 4.08B 283M Dec/2025
Abbott USD 4.92B 535M Dec/2025
AngioDynamics USD 37.29M 786K Sep/2025
Anika Therapeutics USD 11.44M 797K Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Globus Medical USD 290.47M 8.09M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
J&J USD 7.97B 689M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Olympus JPY 96.15B 9.61B Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
STAAR Surgical USD 14.06M 2.8M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 33.03M 24.58M Sep/2024
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025